Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04792216 · ClinicalTrials.gov registry record · NA

Salmon Intake and Gut Health in Adults

A NA study of Inflammation and Gut Microbiome, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04792216 is a NA study of Inflammation and Gut Microbiome that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04792216, a NA study of Inflammation and Gut Microbiome, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this project is to determine the interplay of salmon as a whole food and its bioactive compound astaxanthin on gut microbiome, fecal metabolome, and inflammation in obese prediabetic individuals. Our central hypothesis is that dietary bioactive astaxanthin in the form of whole food salmon will effectively reduce inflammation in obese prediabetic individuals, and favorably change the gut microbiota composition and diversity. The investigators anticipate that these changes will result in improved metabolic outcomes in obesity and type 2 diabetes. The two primary aims include: Aim 1: Assess the anti-inflammatory effect of the salmon dietary intervention and the underlying mechanisms on the change in plasma levels of inflammatory cytokines important for the host immune response. Aim 2: Identify whether the relationship between salmon consumption and decreased inflammation is mediated by the gut microbiome.

Conditions Studied

Inflammation Gut Microbiome

Interventions

  • OTHER Wild Salmon
  • OTHER Farmed Salmon

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-08-01
Est. Completion 2023-04-30
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04792216

The ClinicalTrials.gov registry entry for NCT04792216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (86% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Wild Salmon is the first listed.

NCT04792216 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04792216 about?

NCT04792216 is a clinical study titled "Salmon Intake and Gut Health in Adults". The overall objective of this project is to determine the interplay of salmon as a whole food and its bioactive compound astaxanthin on gut microbiome, fecal metabolome, and inflammation in obese prediabetic individuals. Our central hypothesis is that dietary bioactive astaxanthin in the form of who...

What is the current status of trial NCT04792216?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-08-01. Estimated completion is 2023-04-30.

What conditions does trial NCT04792216 study?

This clinical trial studies the following conditions: Inflammation, Gut Microbiome.

What interventions are being tested in trial NCT04792216?

The interventions under investigation include: Wild Salmon (OTHER), Farmed Salmon (OTHER).

Who is sponsoring clinical trial NCT04792216?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04792216 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Inflammation

All registered trials for this condition

Gut Microbiome

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.